Human Reproductive Technologies Market is witnessing robust growth with Ferring Pharmaceuticals collaborating with Rebiotix Inc. and MyBiotics Pharma Ltd. to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women
Human Reproductive Technologies is the use of science to help in the process of reproduction. The term Human Reproductive Technologies covers all medical interventions that are used to help people have children. The market for Human Reproductive Technologies is very large and there are many aspects that affect the marketability of a product. The overall costs of such procedures may vary from country to country and may also depend upon the techniques that are being used to perform the procedure. There is a high rate of infertility in North America due to high obesity rates, which is leading to the increased adoption of human reproductive technologies. As per the Centers for Disease Control and Prevention (CDC), in 2021, around 40% of adults aged 20 to 39 years were obese. On the contrary, Asia Pacific is gaining significant traction in the human reproductive technologies market since there is a high population coupled with growing awareness regarding reproductive technologies. T...